Clincosm LogoSign in Get a demo

Obesity

Showing NaN - NaN of 88
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Kidney Disease, Type 2 Diabetes, Obesity Trial in Worldwide (Cagrilintide, Semaglutide, Placebo)

Not yet recruiting
  • Chronic Kidney Disease
  • +2 more
  • Concord, California
  • +73 more
Nov 9, 2023

Overweight, Obesity Trial in United States (Tirzepatide, Placebo)

Not yet recruiting
  • Overweight
  • Obesity
  • Pelham, Alabama
  • +19 more
Sep 14, 2023

Insulin Resistance, Polycystic Ovary Syndrome, Hyperinsulinism Trial in Houston

Not yet recruiting
  • Insulin Resistance
  • +4 more
    • Houston, Texas
      Lilli Health
    Jul 10, 2023

    Obesity, Overweight, Knee Pain Chronic Trial in Worldwide (Retatrutide, Placebo)

    Not yet recruiting
    • Obesity
    • +4 more
    • Phoenix, Arizona
    • +168 more
    Jul 10, 2023

    Obesity Trial in Houston, San Antonio, Charlottesville (S-309309, Placebo)

    Recruiting
    • Obesity
    • Houston, Texas
    • +2 more
    Jun 30, 2023

    Obesity, Overweight, Type 2 Diabetes Trial in Worldwide (Orforglipron, Placebo)

    Not yet recruiting
    • Obesity
    • +2 more
    • Pelham, Alabama
    • +135 more
    May 15, 2023

    Obesity, Overweight, Overweight or Obesity Trial in Worldwide (Orforglipron, Placebo)

    Not yet recruiting
    • Obesity
    • +2 more
    • Mesa, Arizona
    • +134 more
    May 12, 2023

    Obesity, Overweight Trial in Puerto Rico, United States (Tirzepatide, Semaglutide 2.4 mg)

    Recruiting
    • Obesity
    • Overweight
    • Birmingham, Alabama
    • +31 more
    Apr 26, 2023

    Type 2 Diabetes, Obesity, Overweight or Obesity Trial in Worldwide (Orforglipron, Insulin Glargine)

    Recruiting
    • Type 2 Diabetes
    • +5 more
    • Muscle Shoals, Alabama
    • +320 more
    Apr 12, 2023

    Obesity Trial in Worldwide (Cagrilintide, Semaglutide, Placebo)

    Not yet recruiting
    • Obesity
    • Birmingham, Alabama
    • +253 more
    Jan 24, 2023

    Overweight, Obesity and Diabetes, Type 2 Trial (Cagrilintide, Semaglutide, Placebo cagrilintide)

    Not yet recruiting
    • Overweight
    • +2 more
    • Concord, California
    • +147 more
    Jan 24, 2023

    Obesity, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo)

    Recruiting
    • Obesity
    • Diabetes Mellitus, Type 2
    • Birmingham, Alabama
    • +73 more
    Jan 24, 2023

    Obesity Trial in Worldwide (semaglutide 2.4 mg, semaglutide 2.4 mg ())

    Active, not recruiting
    • Obesity
    • semaglutide 2.4 mg
    • semaglutide 2.4 mg (placebo)
    • Montgomery, Alabama
    • +64 more
    Jan 24, 2023

    Obesity, Overweight Trial in Worldwide (Tirzepatide, Placebo)

    Recruiting
    • Obesity
    • Overweight
    • Gilbert, Arizona
    • +695 more
    Jan 18, 2023

    Pro-opiomelanocortin (POMC) Deficiency Obesity (Heterozygous or Epigenetic), Leptin Receptor Deficiency Obesity, Smith-Magenis

    Completed
    • Genetic Obesity
    • +2 more
    • Birmingham, Alabama
    • +57 more
    Dec 22, 2022

    Overweight, Obesity Trial in Worldwide (Semaglutide, Placebo (semaglutide))

    Active, not recruiting
    • Overweight
    • Obesity
    • Birmingham, Alabama
    • +804 more
    Dec 19, 2022

    Diabetes, Obesity Trial in United States (PF-06882961, Placebo)

    Completed
    Has Results
    • Diabetes
    • Obesity
    • Phoenix, Arizona
    • +37 more
    Nov 8, 2022

    Obesity, Obesity, Childhood, Physical Activity Trial in Houston (Healthy Dads Healthy Kids, Standard of care control)

    Recruiting
    • Obesity
    • +3 more
    • Healthy Dads Healthy Kids
    • Standard of care control
    • Houston, Texas
      Baylor College of Medicine
    Oct 24, 2022

    Deleterious BRCA1 Gene Mutation, Deleterious BRCA2 Gene Mutation, Ductal Breast Carcinoma In Situ Trial in Houston (Behavioral,

    Active, not recruiting
    • Deleterious BRCA1 Gene Mutation
    • +5 more
    • Behavioral, Psychological or Informational Intervention
    • Questionnaire Administration
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 22, 2022

    Nutrition, Healthy, Mental Health Wellness 1, Diabetes Risk Trial in Houston (Brighter Bites (BB) Produce Distribution, Brighter

    Not yet recruiting
    • Nutrition, Healthy
    • +3 more
    • Brighter Bites (BB) Produce Distribution
    • +3 more
    • Houston, Texas
      The University of Texas Health Science Center at Houston
    Sep 12, 2022

    Obesity Trial in Palo Alto, Houston (EMBER, Control)

    Not yet recruiting
    • Obesity
    • EMBER
    • Control
    • Palo Alto, California
    • +1 more
    Aug 17, 2022

    Obesity Trial in Houston (Group 1 (First trimester ultrasound), Group 2 (Second trimester anatomy ultrasound))

    Active, not recruiting
    • Obesity
    • Group 1 (First trimester ultrasound)
    • Group 2 (Second trimester anatomy ultrasound)
    • Houston, Texas
      The University of Texas Health Science Center at Houston
    Jun 1, 2022

    Obesity, Overweight Trial in Puerto Rico, United States (LY3437943, Placebo)

    Active, not recruiting
    • Obesity
    • Overweight
    • Scottsdale, Arizona
    • +27 more
    May 10, 2022

    Type 2 Diabetes, Overweight, Obesity Trial in Worldwide (Tirzepatide, Placebo)

    Active, not recruiting
    • Type 2 Diabetes
    • +2 more
    • Birmingham, Alabama
    • +74 more
    Apr 18, 2022

    Obesity, Type 2 Diabetes Trial in Houston (SSC Program, Written Handouts)

    Completed
    • Obesity
    • Type 2 Diabetes
    • SSC Program
    • Written Handouts
    • Houston, Texas
    • +1 more
    Apr 11, 2022